SINGAPORE (May 21): Bruno de Pampelonne, chairman of Tikehau Investment Management, admits he is not a doctor; neither does his firm have in-house healthcare experts. However, that will not deter the former Merrill Lynch banker from making big bets on early-stage medical technology and life sciences companies.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

SUBSCRIBE NOW